Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · IEX Real-Time Price · USD

0.285

-0.003 (-0.94%)

At close: Jul 2, 2024, 3:55 PM

0.303

+0.018 (6.20%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Galmed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2012
Market Capitalization	2	2	13	46	66	121	Upgrade
Market Cap Growth	-87.09%	-85.53%	-72.40%	-30.56%	-45.89%	23.22%	Upgrade
Enterprise Value	-9	-11	-1	11	15	46	Upgrade
PE Ratio	-	-0.26	-0.70	-1.41	-2.28	-5.94	Upgrade
PB Ratio	0.13	0.13	0.94	1.50	1.49	1.74	Upgrade
P/FCF Ratio	-0.22	-0.30	-0.68	-1.39	-2.50	-8.13	Upgrade
P/OCF Ratio	-0.22	-0.30	-0.68	-1.39	-2.50	-8.13	Upgrade
EV/EBITDA Ratio	1.39	1.47	0.07	-0.33	-0.50	-2.07	Upgrade
EV/EBIT Ratio	1.38	1.46	0.07	-0.33	-0.50	-2.07	Upgrade
EV/FCF Ratio	1.52	1.78	0.07	-0.33	-0.57	-3.09	Upgrade
Debt / Equity Ratio	-	-	0.00	0.01	0.00	0.01	Upgrade
Debt / EBITDA Ratio	-	-	0.00	-0.01	-0.01	-0.02	Upgrade
Debt / FCF Ratio	-	-	0.00	-0.01	-0.01	-0.02	Upgrade
Quick Ratio	6.34	4.81	4.76	6.13	6.47	11.02	Upgrade
Current Ratio	6.34	4.81	4.76	6.13	6.47	11.02	Upgrade
Interest Coverage	-	-	-82.10	-	-	-	Upgrade
Return on Equity (ROE)	-48.30%	-53.30%	-96.20%	-78.20%	-51.90%	-26.10%	Upgrade
Return on Assets (ROA)	-41.00%	-44.40%	-78.40%	-67.10%	-46.50%	-24.70%	Upgrade
Return on Capital (ROIC)	-54.02%	-53.98%	-131.07%	-107.01%	-68.09%	-31.87%	Upgrade
Earnings Yield	-370.77%	-379.13%	-141.77%	-71.12%	-43.76%	-16.84%	Upgrade
FCF Yield	-365.81%	-336.62%	-146.85%	-72.07%	-40.05%	-12.30%	Upgrade
Buyback Yield / Dilution	-222.67%	-65.23%	-2.22%	-15.59%	-0.79%	-16.41%	Upgrade
Total Shareholder Return	-222.67%	-65.23%	-2.22%	-15.59%	-0.79%	-16.41%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).